139 related articles for article (PubMed ID: 2392503)
1. Close correlation between behavioural response and binding in vivo for inhibitors of the rolipram-sensitive phosphodiesterase.
Schmiechen R; Schneider HH; Wachtel H
Psychopharmacology (Berl); 1990; 102(1):17-20. PubMed ID: 2392503
[TBL] [Abstract][Full Text] [Related]
2. Species differences in behavioural effects of rolipram and other adenosine cyclic 3H, 5H-monophosphate phosphodiesterase inhibitors.
Wachtel H
J Neural Transm; 1983; 56(2-3):139-52. PubMed ID: 6190991
[TBL] [Abstract][Full Text] [Related]
3. Antidepressant properties of some phosphodiesterase inhibitors.
Przegaliński E; Bigajska K
Pol J Pharmacol Pharm; 1983; 35(3):233-40. PubMed ID: 6194518
[TBL] [Abstract][Full Text] [Related]
4. Potential antidepressant activity of rolipram and other selective cyclic adenosine 3',5'-monophosphate phosphodiesterase inhibitors.
Wachtel H
Neuropharmacology; 1983 Mar; 22(3):267-72. PubMed ID: 6302550
[TBL] [Abstract][Full Text] [Related]
5. Characteristic behavioural alterations in rats induced by rolipram and other selective adenosine cyclic 3', 5'-monophosphate phosphodiesterase inhibitors.
Wachtel H
Psychopharmacology (Berl); 1982; 77(4):309-16. PubMed ID: 6182575
[TBL] [Abstract][Full Text] [Related]
6. Biarylcarboxylic acids and -amides: inhibition of phosphodiesterase type IV versus [3H]rolipram binding activity and their relationship to emetic behavior in the ferret.
Duplantier AJ; Biggers MS; Chambers RJ; Cheng JB; Cooper K; Damon DB; Eggler JF; Kraus KG; Marfat A; Masamune H; Pillar JS; Shirley JT; Umland JP; Watson JW
J Med Chem; 1996 Jan; 39(1):120-5. PubMed ID: 8568798
[TBL] [Abstract][Full Text] [Related]
7. Calcium-independent phosphodiesterase inhibitors as putative antidepressants: [3-(bicycloalkyloxy)-4-methoxyphenyl]-2-imidazolidinones.
Saccomano NA; Vinick FJ; Koe BK; Nielsen JA; Whalen WM; Meltz M; Phillips D; Thadieo PF; Jung S; Chapin DS
J Med Chem; 1991 Jan; 34(1):291-8. PubMed ID: 1992129
[TBL] [Abstract][Full Text] [Related]
8. Rolipram, a novel antidepressant drug, reverses the hypothermia and hypokinesia of monoamine-depleted mice by an action beyond postsynaptic monoamine receptors.
Wachtel H; Schneider HH
Neuropharmacology; 1986 Oct; 25(10):1119-26. PubMed ID: 2946976
[TBL] [Abstract][Full Text] [Related]
9. Inhibitors of phosphodiesterase IV (PDE IV) increase acid secretion in rabbit isolated gastric glands: correlation between function and interaction with a high-affinity rolipram binding site.
Barnette MS; Grous M; Cieslinski LB; Burman M; Christensen SB; Torphy TJ
J Pharmacol Exp Ther; 1995 Jun; 273(3):1396-402. PubMed ID: 7791113
[TBL] [Abstract][Full Text] [Related]
10. Neurotropic effects of the optical isomers of the selective adenosine cyclic 3',5'-monophosphate phosphodiesterase inhibitor rolipram in rats in-vivo.
Wachtel H
J Pharm Pharmacol; 1983 Jul; 35(7):440-4. PubMed ID: 6136585
[TBL] [Abstract][Full Text] [Related]
11. Phosphodiesterase 4 in macrophages: relationship between cAMP accumulation, suppression of cAMP hydrolysis and inhibition of [3H]R-(-)-rolipram binding by selective inhibitors.
Kelly JJ; Barnes PJ; Giembycz MA
Biochem J; 1996 Sep; 318 ( Pt 2)(Pt 2):425-36. PubMed ID: 8809029
[TBL] [Abstract][Full Text] [Related]
12. Discriminative stimulus properties of the stereoisomers of the phosphodiesterase inhibitor rolipram.
Schneider HH; Yamaguchi M; Andrews JS; Stephens DN
Pharmacol Biochem Behav; 1995 Feb; 50(2):211-7. PubMed ID: 7740060
[TBL] [Abstract][Full Text] [Related]
13. Nicotinamide ethers: novel inhibitors of calcium-independent phosphodiesterase and [3H]rolipram binding.
Vinick FJ; Saccomano NA; Koe BK; Nielsen JA; Williams IH; Thadeio PF; Jung S; Meltz M; Johnson J; Lebel LA
J Med Chem; 1991 Jan; 34(1):86-9. PubMed ID: 1825116
[TBL] [Abstract][Full Text] [Related]
14. The ability of phosphodiesterase IV inhibitors to suppress superoxide production in guinea pig eosinophils is correlated with inhibition of phosphodiesterase IV catalytic activity.
Barnette MS; Manning CD; Cieslinski LB; Burman M; Christensen SB; Torphy TJ
J Pharmacol Exp Ther; 1995 May; 273(2):674-9. PubMed ID: 7752069
[TBL] [Abstract][Full Text] [Related]
15. Influence of aging on rolipram-sensitive phosphodiesterase activity and [3H]rolipram binding in the rat brain.
Tohda M; Murayama T; Nogiri S; Nomura Y
Biol Pharm Bull; 1996 Feb; 19(2):300-2. PubMed ID: 8850327
[TBL] [Abstract][Full Text] [Related]
16. Evidence that cyclic AMP phosphodiesterase inhibitors suppress TNF alpha generation from human monocytes by interacting with a 'low-affinity' phosphodiesterase 4 conformer.
Souness JE; Griffin M; Maslen C; Ebsworth K; Scott LC; Pollock K; Palfreyman MN; Karlsson JA
Br J Pharmacol; 1996 Jun; 118(3):649-58. PubMed ID: 8762090
[TBL] [Abstract][Full Text] [Related]
17. Autoradiographic mapping of a selective cyclic adenosine monophosphate phosphodiesterase in rat brain with the antidepressant [3H]rolipram.
Kaulen P; Brüning G; Schneider HH; Sarter M; Baumgarten HG
Brain Res; 1989 Dec; 503(2):229-45. PubMed ID: 2557965
[TBL] [Abstract][Full Text] [Related]
18. Stimulation of the hypothalamo-pituitary-adrenal axis in the rat by three selective type-4 phosphodiesterase inhibitors: in vitro and in vivo studies.
Kumari M; Cover PO; Poyser RH; Buckingham JC
Br J Pharmacol; 1997 Jun; 121(3):459-68. PubMed ID: 9179387
[TBL] [Abstract][Full Text] [Related]
19. Antidepressant-like effects of PDE4 inhibitors mediated by the high-affinity rolipram binding state (HARBS) of the phosphodiesterase-4 enzyme (PDE4) in rats.
Zhang HT; Zhao Y; Huang Y; Deng C; Hopper AT; De Vivo M; Rose GM; O'Donnell JM
Psychopharmacology (Berl); 2006 Jun; 186(2):209-17. PubMed ID: 16586089
[TBL] [Abstract][Full Text] [Related]
20. The effect of a selective phosphodiesterase inhibitor, rolipram, on muricide in olfactory bulbectomized rats.
Mizokawa T; Kimura K; Ikoma Y; Hara K; Oshino N; Yamamoto T; Ueki S
Jpn J Pharmacol; 1988 Nov; 48(3):357-64. PubMed ID: 2906101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
